88 related articles for article (PubMed ID: 15231379)
1. Elevation of CK-MB following percutaneous coronary intervention.
Katritsis DG
Eur Heart J; 2004 Jul; 25(13):1180. PubMed ID: 15231379
[No Abstract] [Full Text] [Related]
2. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Nienhuis MB; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Gosselink AT; Suryapranata H; van't Hof AW;
Am Heart J; 2008 Apr; 155(4):673-9. PubMed ID: 18371475
[TBL] [Abstract][Full Text] [Related]
3. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
[TBL] [Abstract][Full Text] [Related]
4. Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatine kinase-MB versus rise of serum creatinine.
Lindsay J; Canos DA; Apple S; Pinnow E; Aggrey GK; Pichard AD
Am J Cardiol; 2004 Sep; 94(6):786-9. PubMed ID: 15374790
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
[TBL] [Abstract][Full Text] [Related]
6. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
Cavallini C; Savonitto S; Violini R; Arraiz G; Plebani M; Olivari Z; Rubartelli P; Battaglia S; Niccoli L; Steffenino G; Ardissino D;
Eur Heart J; 2005 Aug; 26(15):1494-8. PubMed ID: 15741227
[TBL] [Abstract][Full Text] [Related]
7. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker.
Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N
J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525
[TBL] [Abstract][Full Text] [Related]
8. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
[TBL] [Abstract][Full Text] [Related]
9. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
[TBL] [Abstract][Full Text] [Related]
10. Prognostic importance of myonecrosis after percutaneous coronary interventions.
Dangas G
J Invasive Cardiol; 2001 Mar; 13(3):247-50; discussion 266-70. PubMed ID: 11231658
[TBL] [Abstract][Full Text] [Related]
11. Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves.
Ramsay J; Shernan S; Fitch J; Finnegan P; Todaro T; Filloon T; Nussmeier NA
J Thorac Cardiovasc Surg; 2005 Feb; 129(2):300-6. PubMed ID: 15678039
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of creatine kinase release after percutaneous coronary intervention.
Cavallini C; Rugolotto M; Savonitto S
Ital Heart J; 2005 Jun; 6(6):522-9. PubMed ID: 16008158
[TBL] [Abstract][Full Text] [Related]
13. Elective coronary revascularization, an iatrogenic form of acute coronary syndrome: how can clinicians reduce the risks?
Mukherjee D; Oz M; Prager R; Eagle KA
Am Heart J; 2004 Sep; 148(3):371-7. PubMed ID: 15389221
[No Abstract] [Full Text] [Related]
14. Preprocedural plasma C-reactive protein levels, postprocedural creatine kinase-MB release, and long-term prognosis after successful coronary stenting (four-year results from the GENERATION study).
Zairis MN; Ambrose JA; Ampartzidou O; Lyras AG; Manousakis SJ; Makrygiannis SS; Beldekos DJ; Devoe MC; Fakiolas CN; Prekates AA; Olympios CD; Argyrakis SK; Foussas SG;
Am J Cardiol; 2005 Feb; 95(3):386-90. PubMed ID: 15670550
[TBL] [Abstract][Full Text] [Related]
15. [Determination of creatine kinase and CK-MB in heart failure (author's transl)].
Chemnitz G; Schmidt E; Schmidt FW; Gahl K; Lobers J
Med Klin; 1978 Dec; 73(51-52):1809-11. PubMed ID: 723768
[TBL] [Abstract][Full Text] [Related]
16. Stents versus bypass grafting for left main coronary artery disease.
Arnold JR; Banning AP
N Engl J Med; 2008 Jul; 359(4):424-5; author reply 425. PubMed ID: 18655246
[No Abstract] [Full Text] [Related]
17. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes.
Bhatt DL; Topol EJ
Circulation; 2005 Aug; 112(6):906-15; discussion 923. PubMed ID: 16087811
[No Abstract] [Full Text] [Related]
18. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
[TBL] [Abstract][Full Text] [Related]
19. Prognostic importance of troponin T and creatine kinase after elective angioplasty.
Nienhuis MB; Ottervanger JP; Dikkeschei B; Suryapranata H; de Boer MJ; Dambrink JH; Hoorntje JC; van 't Hof AW; Gosselink M; Zijlstra F
Int J Cardiol; 2007 Aug; 120(2):242-7. PubMed ID: 17182137
[TBL] [Abstract][Full Text] [Related]
20. Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).
Linefsky JP; Lin M; Pieper KS; Reist CJ; Berdan LG; Antman EM; Goodman SG; French JK; Guneri S; Roe MT; Newby LK; Harrington RA; Ferguson JJ; Califf RM; Mahaffey KW
Am J Cardiol; 2009 Nov; 104(10):1330-5. PubMed ID: 19892046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
